Carbonic Anhydrase Inhibitors: Inhibition of Transmembrane, Tumor-Associated Isozyme IX, and Cytosolic Isozymes I and II with Aliphatic Sulfamates

Journal of Medicinal Chemistry

Volumn 46, Issue 25, 2003, Pages 5471-5477

  Winum, Jean Yves ^a   Vullo, Daniela ^b   Casini, Angela ^b   Montero, Jean Louis ^a   Scozzafava, Andrea ^b   Supuran, Claudiu T ^b  

^a UNIV MONTPELLIER   (France)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

7ALPHA HYDROXYDEHYDROEPIANDROSTERONE SULFAMATE; ANTINEOPLASTIC AGENT; BENZYL SULFAMATE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IX; MEMBRANE PROTEIN; N DODECYL SULFAMATE; N TETRADECYL SULFAMATE; PHENETHYL SULFAMATE; UNCLASSIFIED DRUG; ZINC;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL MEMBRANE; CYTOSOL; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HYPOXIA; NONHUMAN; PARAMETER; PROTEIN EXPRESSION;

ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; CARBONIC ANHYDRASE I; CARBONIC ANHYDRASE II; CARBONIC ANHYDRASES; CYTOSOL; ENZYME INHIBITORS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONIC ACIDS;

EID: 0344981308     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030911u     Document Type: Article

References (33)

1. Winum, J.-Y.; Vullo, D.; Casini, A.; Montero, J.-L.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: Inhibition of cytosolic isozymes I and II and the transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors. J. Med. Chem. 2003, 46, 2197-2204.
2. (a) Smith, H. J.; Nicholls, P. J.; Simons, C.; Le Lain, R. Inhibitors of steroidogenesis as agents for the treatment of hormone-dependent cancers. Exp. Opin. Ther. Patents 2001, 11, 789-824.
3. (b) Ahmed, S.; Owen, C. P.; James, K.; Sampson, L.; Patel, C. K. Review of estrone sulfatase and its inhibitors-an important new target against hormone dependent breast cancer. Curr. Med. Chem. 2002, 9, 263-273.
4. Supuran, C. T.; Scozzafava, A.; Casini, A. Carbonic anhydrase inhibitors. Med. Res. Rev. 2003, 23, 146-189.
5. (a) Supuran, C. T.; Scozzafava, A. Applications of carbonic anhydrase inhibitors and activators in therapy. Exp. Opin. Ther. Patents 2002, 12, 217-242.
6. (b) Supuran C. T.; Scozzafava, A. Carbonic anhydrase inhibitors and their therapeutic potential. Exp. Opin. Ther. Patents 2000, 10, 575-600.
7. Supuran, C. T.; Scozzafava, A. Carbonic anhydrase inhibitors. Curr. Med. Chem.-Imm., Endoc. Metab. Agents 2001, 1, 61-97.
8. (a) Scozzafava, A.; Owa, T.; Mastrolorenzo, A.; Supuran, C. T. Anticancer and antiviral sulfonamides. Curr. Med. Chem. 2003, 10, 925-953.
9. (b) Casini, A.; Scozzafava, A.; Mastrolorenzo, A.; Supuran, C. T. Sulfonamides and sulfonylated derivatives as anticancer agents. Curr. Cancer Drug Targets 2002, 2, 55-75.
10. (a) Chegwidden, W. R.; Spencer, I. M.; Supuran, C. T. The roles of carbonic anhydrase isozymes in cancer. In Gene Families: Studies of DNA, RNA, Enzymes and Proteins; Xue, G., Xue, Y., Xu, Z., Holmes, R., Hammond, G. L., Lim, H. A., Eds.; World Scientific: Singapore, 2001; pp 157-170
11. (b) Wykoff, C. C.; Beasley, N.; Watson, P. H.; Turner, K. J.; Pastorek, J.; Sibtain, A.; Wilson, G. D.; Turley, H.; Talks, K. L.; Maxwell, P. H.; Pugh, C. W.; Ratcliffe, P.; Harris, A. L. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 2000, 60, 7075-7083.
12. (c) Höckel, M.; Vaupel, P. Tumor hypoxia: Definitions and current clinical, biologic and molecular aspects. J. Natl. Cancer Inst. 2001, 93, 266-276.
13. Pastorekova, S.; Pastorek, J. Cancer-related carbonic anhydrase isozymes and their inhibition. In Carbonic anhydrase, its inhibitors and activators; Supuran, C. T., Scozzafava, A., Conway J., Eds.; Taylor & Francis: London & New York, 2003; in press.
14. (a) Vullo, D.; Franchi, M.; Gallori, E.; Pastorek, J.; Scozzafava, A.; Pastorekova, S.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. Bioorg. Med. Chem. Lett. 2003, 13, 1005-1009.
15. (b) Ilies, M. A.; Vullo, D.; Pastorek, J.; Scozzafava, A.; Ilies, M.; Caproiu, M. T.; Pastorekova, S.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX with halogenosulfanilamide and halogenophenylaminobenzolamide derivatives. J. Med. Chem. 2003, 46, 2187-2196.
16. (c) Franchi, M.; Vullo, D.; Gallori, E.; Pastorek, J.; Russo, A.; Scozzafava, A.; Pastorekova, S.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides. J. Enzymol. Inhib. Med. Chem. 2003, 18, 333-338.
17. Ho, Y. T.; Purohit, A.; Vicker, N.; Newman, S. P.; Robinson, J. J.; Leese, M. P.; Ganeshapillai, D.; Woo, L. W. L.; Potter, B. V. L.; Reed, M. J. Inhibition of carbonic anhydrase II by steroidal and nonsteroidal sulphamates. Biochem. Biophys. Res. Commun. 2003, 305, 909-914.
18. Okada, M.; Iwashita, S.; Koizumi, N. Efficient general method for sulfamoylation of a hydroxyl group. Tetrahedron Lett. 2000, 41, 7057-7051.
19. Appel, R.; Berger, G. Hydrazinsulfonsaüre-amide, I. Über das hydrazodisulfamid. Chem. Ber. 1958, 91, 1339-1341.
20. Spillane, W. J.; Taheny, A. P.; Kearns, M. Versatile synthesis of sulfamate esters by phase-transfert methods. J. Chem. Soc., Perkin Trans. 1 1982, 3, 677-679.
21. Appel, R.; Senkpiel, W.; Sulfamates. Z. Anorg. U. Allg. Chem. 1961, 310, 94-99.
22. Kinkead, S. A.; Kumar, R. C.; Shreeve, J. M. Reaction of polyfluoroalkyl fluorosulfates with nucleophiles: An unusual substitution at the sulfur-fluorine bond. J. Am. Chem. Soc. 1984, 106, 7496-7500.
23. Ahmed, S.; Owen, C. P.; James, K.; Patel, C. K.; Sampson, L. Evidence for the mechanism of the irreversible inhibition of oestrone sulphatase (ES) by aminosulphonate based compounds. J. Steroid Biochem. Mol. Biol. 2002, 80, 429-440.
24. Lindskog, S.; Behravan, G.; Engstrand, C.; Forsman, C.; Jonsson, B. H.; Liang, Z.; Ren, X.; Xue, Y. Structure-function relations in human carbonic anhydrase II as studied by site-directed mutagenesis. In Carbonic anhydrase-From biochemistry and genetics to physiology and clinical medicine; Botrè, F., Gros, G., Storey, B. T., Eds.; VCH: Weinheim, 1991; pp 1-13.
25. Behravan, G.; Jonsson, B. H.; Lindskog, S. Fine-tuning of the catalytic properties of carbonic anhydrase. Studies of a Thr200-His variant of human isoenzyme II. Eur. J. Biochem. 1990, 190, 351-357.
26. Khalifah, R. G.; Strader, D. J.; Bryant, S. H.; Gibson, S. M. Carbon-13 nuclear magnetic resonance probe of active site ionization of human carbonic anhydrase B. Biochemistry 1977, 16, 2241-2247.
27. Lindskog, S.; Coleman, J. E. The catalytic mechanism of carbonic anhydrase. Proc. Natl. Acad Sci. U.S.A. 1964, 70, 2505-2508.
28. Steiner, H.; Jonsson, B. H.; Lindskog, S. The catalytic mechanism of carbonic anhydrase. Hydrogen-isotope effects on the kinetic parameters of the human C isoenzyme. Eur. J. Biochem. 1975, 59, 253-259.
29. Pastorek, J.; Pastorekova, S.; Callebaut, I.; Mornon, J. P.; Zelnik, V.; Opavsky, R.; Zatovicova, M.; Liao, S.; Portetelle, D.; Stanbridge, E. J.; Zavada, J.; Burny, A.; Kettmann, R. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 1994, 9, 2877-2888.
30. Wingo, T.; Tu, C.; Laipis, P. J.; Silverman, D. N. The catalytic properties of human carbonic anhydrase IX. Biochem. Biophys. Res. Commun. 2001, 288, 666-669.
31. Khalifah, R. G. The carbon dioxide hydration activity of carbonic anhydrase. J. Biol. Chem. 1971, 246, 2561-2573.
32. Maren, T. H.; Conroy, C. W. A new class of carbonic anhydrase inhibitor. J. Biol. Chem. 1993, 268, 26233-26239.
33. Scozzafava, A.; Menabuoni, L.; Mincione, F.; Briganti, F.; Mincione, G.; Supuran, C. T. Carbonic anhydrase inhibitors. Perfluoroalkyl/aryl-substituted derivatives of aromatic/heterocyclic sulfonamides as topical intraocular pressure lowering agents with prolonged duration of action. J. Med. Chem. 2000, 43, 4542-4551.